跳至主要内容
临床试验/NCT01890486
NCT01890486招募中不适用

The Prospective Collection, Storage and Reporting of Data on Patients

Wake Forest University Health Sciences1 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2001年5月21日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
2,000
试验地点
1
主要终点
Data followup

研究概览

简要总结

To provide the IRB approved mechanism for the prospective collection and analysis on participants who are undergoing either an autologous or allogeneic hematopoietic stem cell transplant for a disease in which a research question is not being addressed.

详细描述

To provide an IRB approved mechanism for the prospective collection and analysis on participants who are undergoing either an autologous or allogeneic hematopoietic stem cell transplant or cellular therapies for a disease in which a research question is not being addressed and for which peer reviewed, published data have demonstrated efficacy for this treatment approach.

To provide a consent mechanism for the retrospective study of cellular products, when available, if there is a specific question to be addressed.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 120 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Planned standard of care dose intensive therapy and either an allogeneic or autologous bone marrow transplant

排除标准

  • •Participation in any other treatment research protocol

结局指标

主要结局

Data followup

时间窗: 1 year

Gather basic survival and complication data for operational and research databases for ongoing regulatory and future operational queries

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

招募中
不适用
Data Collection of Patients Admitted to the Stroke UnitStroke SequelaeStroke, IschemicStroke, AcuteStroke HemorrhagicStroke
NCT04956185University Hospital, Ghent5,000
招募中
不适用
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for CancerSpitz NevusCirrhosisLung CancerOsteochondromaChildhood Cancer SurvivorsAdenomatous HyperplasiaHigh-risk Oral Precancerous DiseasesHereditary Cancer PredictionIARC CarcinogensNon-Alcoholic Fatty Liver DiseaseHigh Grade Prostatic Epithelial NeoplasiaSerous Tubal Intraepithelial CarcinomaCervical and Endocervical Carcinoma in SituNephrogenic RestsSmoking HistoryDuctal/Lobular CarcinomaBarrett EsophagusPancreatic Precursor LesionsHigh-grade Bladder Urothelial Dysplasia/Carcinoma in SituMelanocytic Lesion, AdultEndometrial Intraepithelial NeoplasiaCancer RiskCancer Predisposition SyndromeAdult Cancer SurvivorsColonic Dysplasia/AdenomataNon Alcoholic SteatohepatitisHematologic MalignancyVulvar Intraepithelial NeoplasiaBenign Bone Lesions With Risk of Malignant DegenerationGiant Cell TumorNode Lung
NCT05463796Dana-Farber Cancer Institute5,000
招募中
不适用
Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK.Non-Muscle Invasive Bladder NeoplasmsBladder Urothelial CarcinomaBladder NeoplasmNon-Muscle Invasive Bladder Urothelial CarcinomaBladder DiseaseBladder Cancer Stage I, With Cancer in SituBladder Cancer RecurrentBladder Urothelial Carcinoma in SituNon Muscle Invasive Bladder CancerBladder Urothelial DysplasiaBladder Cancer
NCT06167356IRCCS San Raffaele20,000
已完成
不适用
Pediatric Femur Fracture RegistryFemoral Shaft Fracture
NCT03211546AO Innovation Translation Center322
终止
不适用
The Chimerix CMX001 RegistryOutcomesSurvival Rates
NCT02167685Chimerix550